Evidence map›Paper›PMID 34930535›Full record

ArticleJournal of cystic fibrosis : official journal of the European Cystic Fibrosis Society2021

Financial impacts of the COVID-19 pandemic on cystic fibrosis care: lessons for the future.

Gregory S Sawicki, Aricca D Van Citters, Olivia Dieni, Kathryn A Sabadosa, Anne Willis, Debbie Benitez, Thida Ong, Elliott C Dasenbrook

Open access · hybridAbstract read
In one paragraph

Article in Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The Impact of COVID-19 in Cystic Fibrosis.Archivos de bronconeumologia · 2022
    Article
  6. A year in review: Real world evidence, functional monitoring and emerging therapeutics in 2021.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2022
    Review
  7. Financial impacts of the COVID-19 pandemic on cystic fibrosis care: Lessons for the future (Commentary) A.L. Stephenson.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2021
    Article
  8. Evaluating barriers to and promoters of telehealth during the COVID-19 pandemic at U.S. cystic fibrosis programs.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2021
    Article
  9. Design and methods for understanding the state of cystic fibrosis care amid the COVID-19 pandemic.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2021
    Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 2 countries.

Gregory S SawickiDivision of Pulmonary Medicine, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA 02115 United States. Electronic address: gregory.sawicki@childrens.harvard.edu.
Aricca D Van CittersThe Dartmouth Institute for Health Policy & Clinical Practice, Geisel School of Medicine at Dartmouth, Williamson Translational Research Building, Level 5, One Medical Center Drive, Lebanon, NH 03766 United States.
Olivia DieniCystic Fibrosis Foundation, 4550 Montgomery Avenue, Suite 1100N, Bethesda, MD 20814 United States.
Kathryn A SabadosaCystic Fibrosis Foundation, 4550 Montgomery Avenue, Suite 1100N, Bethesda, MD 20814 United States.
Anne WillisCystic Fibrosis Foundation, 4550 Montgomery Avenue, Suite 1100N, Bethesda, MD 20814 United States.
Debbie BenitezKeck Medical Center, University of Southern California, 1510 San Pablo Street Suite #514, Los Angeles, CA 90033 United States.
Thida OngDivision of Pulmonary and Sleep Medicine, Seattle Children's Hospital, M/S OC 7.720, PO Box 5371, Seattle, WA 98145 United States.
Elliott C DasenbrookCleveland Clinic Respiratory Institute; 9500 Euclid Avenue; A90; Cleveland, OH 44141 United States.
Cystic Fibrosis Foundation · USBoston Children's Hospital · USCleveland Clinic · USDartmouth Institute for Health Policy and Clinical Practice · USSeattle Children's Hospital · USUniversity of Southern California · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic care delivery models faced unprecedented financial pressures, with a reduction of in-person visits and adoption of telehealth during the COVID-19 pandemic. We sought to understand the reported financial impact of pandemic-related changes to the cystic fibrosis (CF) care model.

methodsThe U.S. CF Foundation State of Care surveys fielded in Summer 2020 (SoC1) and Spring 2021 (SoC2) included questions for CF programs on the impact of pandemic-related restrictions on overall finances, staffing, licensure, and reimbursement of telehealth services. Descriptive analyses were conducted based on program type.

resultsAmong the 286 respondents (128 pediatric, 118 adult, 40 affiliate), the majority (62%) reported a detrimental financial impact to their CF care program in SoC1, though fewer (42%) reported detrimental impacts in SoC2. The most common reported impacts in SoC1 were redeployment of clinical staff (68%), furloughs (52%), hiring freezes (51%), decreases in salaries (34%), or layoffs (10%). Reports of lower reimbursement for telehealth increased from 30% to 40% from SoC1 to SoC2. Projecting towards the future, only a minority (17%) of program directors in SoC2 felt that financial support would remain below pre-pandemic levels.

conclusionsThe COVID-19 pandemic resulted in financial strain on the CF care model, including challenges with reimbursement for telehealth services and reductions in staffing due to institutional changes. Planning for the future of CF care model needs to address these short-term impacts, particularly to ensure a lack of interruption in high-quality multi-disciplinary care.

Indexed as

Continuity of Patient CareCOVID-19Cystic FibrosisHealth Services AccessibilityModels, OrganizationalTelemedicineAdultChildCosts and Cost AnalysisHealth Services Needs and DemandHumansOrganizational InnovationPersonnel Staffing and SchedulingReimbursement MechanismsSARS-CoV-2United StatesCystic fibrosisReimbursementTelehealth

Identifiers

PMID34930535
PMCPMC8711855
OpenAlexW4200468679

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.